Home›Screener›REGN›Profile

F

34/100

Regeneron Pharmaceuticals

REGNAntibody Therapeutics

← Signals View

📋

Analyst Summary

✓ VERIFIED2026-04-11

Regeneron Pharmaceuticals (REGN) is the lead sponsor of 97 active clinical trials listed on ClinicalTrials.gov^[5], including 30 Phase 3^[1], 42 Phase 2^[2], 31 Phase 1^[3], 2 Phase 4^[4].

Trial NCT05394116^[6] evaluates Garetosmab in Fibrodysplasia Ossificans Progressiva with a target enrollment of 63 participants. Trial NCT06230224^[7] evaluates Odronextamab in B-Cell Non-Hodgkin Lymphoma (B-NHL) with a target enrollment of 216 participants. Trial NCT07222761^[8] evaluates Linvoseltamab in Relapsed and/or Refractory Multiple Myeloma (RRMM) with a target enrollment of 915 participants.

REGN has 1 Form 4 insider filing recorded at the SEC in the past 30 days^[9].

Sources

ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov · NCT05394116 (2026-01-16) ↗
ClinicalTrials.gov · NCT06230224 (2026-04-08) ↗
ClinicalTrials.gov · NCT07222761 (2026-04-08) ↗
SEC EDGAR · 0000872589 (2026-04-11) ↗

🏛

Upcoming Catalysts

fianlimab — adjuvant melanoma

2026-06-12

in 8d

dupixent — CSU additional indication

2027-04-25

in 325d

REGN2810 (cemiplimab) — CSCC sNDA adjuvant

2027-02-05

in 246d

dupixent (dupilumab) — chronic rhinosinusitis w/o polyps sNDA

2026-12-18

in 197d

🔬

Clinical Trials

97

NCT02612454Atopic Dermatitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT02651662Relapsed/Refractory Aggressive B-Cell Lymphoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT03233139Advanced Malignancies

clinicaltrials_gov · Retrieved 2026-04-11

NCT03428646Dermatitis, Atopic

clinicaltrials_gov · Retrieved 2026-04-11

NCT03564340Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer, Recurrent Endometrial Cancer, Endometrial Cancer, Low-grade Serous Ovarian Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT03761108Multiple Myeloma

clinicaltrials_gov · Retrieved 2026-04-11

NCT03888105B-cell Non-Hodgkin Lymphoma (B-NHL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT03916627Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Head and Neck Squamous Cell Carcinoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT03936335Adverse Pregnancy Outcomes, Atopic Dermatitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT03969004Cutaneous Squamous Cell Carcinoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT03972657Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT04077099NSCLC

clinicaltrials_gov · Retrieved 2026-04-11

NCT04287621Asthma

clinicaltrials_gov · Retrieved 2026-04-11

NCT04515524Retinopathy of Prematurity

clinicaltrials_gov · Retrieved 2026-04-11

NCT04590326Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT04626635Advanced Solid Tumors

clinicaltrials_gov · Retrieved 2026-04-11

NCT04959448Chronic Rhinosinusitis With Nasal Polyposis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05070858Generalized Myasthenia Gravis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05092347Chronic Kidney Disease (CKD)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05106387Chronic Kidney Disease (CKD)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05125016Metastatic Castration-resistant Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05133531Paroxysmal Nocturnal Hemoglobinuria

clinicaltrials_gov · Retrieved 2026-04-11

NCT05137054Multiple Myeloma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05259709Advanced Solid Tumor, Metastatic Solid Tumor

clinicaltrials_gov · Retrieved 2026-04-11

NCT05352672Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05363319Non-small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05394116Fibrodysplasia Ossificans Progressiva

clinicaltrials_gov · Retrieved 2026-04-11

NCT05519475Metabolic Dysfunction-associated Steatohepatitis (MASH)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05557591Advanced Non-Small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05568459Hemophilia B

clinicaltrials_gov · Retrieved 2026-04-11

NCT05608291Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05648214Healthy Volunteers, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05685173B-cell Non-Hodgkins Lymphoma (B-NHL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05730036Relapsed Refractory Multiple Myeloma (RRMM)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05744921Paroxysmal Nocturnal Hemoglobinuria

clinicaltrials_gov · Retrieved 2026-04-11

NCT05785767Advanced Non-Small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05788536Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05800015Non-small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05828511Multiple Myeloma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05955508Smoldering Multiple Myeloma (SMM)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06091254Follicular Lymphoma (FL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06091865Diffuse Large B-cell Lymphoma (DLBCL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06097364Follicular Lymphoma (FL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06140524Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06149286Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06161441Resectable Non-small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06190951Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06230224B-Cell Non-Hodgkin Lymphoma (B-NHL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06246916Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06269133Advanced Non-small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06292780Relapsed/Refractory Systemic Light Chain Amyloidosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06299098Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT06299111Venous Thromboembolism

clinicaltrials_gov · Retrieved 2026-04-11

NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene

clinicaltrials_gov · Retrieved 2026-04-11

NCT06369467Food Allergy

clinicaltrials_gov · Retrieved 2026-04-11

NCT06379789Hemophilia B

clinicaltrials_gov · Retrieved 2026-04-11

NCT06413680Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC), Advanced Solid Tumors

clinicaltrials_gov · Retrieved 2026-04-11

NCT06421636Non-Transfusion Dependent Beta-Thalassemia (NTDT)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06452771Healthy Volunteers With Hyperlipidemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06465329Non-Small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06469281Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06491914Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema

clinicaltrials_gov · Retrieved 2026-04-11

NCT06541704Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06548100Generalized Lipodystrophy

clinicaltrials_gov · Retrieved 2026-04-11

NCT06572228Asthma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06585410Cutaneous Squamous Cell Carcinoma (CSCC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06593600Postural Orthostatic Tachycardia Syndrome (POTS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06608901Sepsis-Induced Hypotension

clinicaltrials_gov · Retrieved 2026-04-11

NCT06669234Healthy Volunteer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06669247Relapsed/Refractory Multiple Myeloma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06693531Eosinophilic Esophagitis (EoE)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06769698Head and Neck Squamous Cell Carcinoma (HNSCC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06787612Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06798298Long Term Safety Following GM T Cell Therapy

clinicaltrials_gov · Retrieved 2026-04-11

NCT06836609Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06848088Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06975787Lupus Nephritis (LN)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07015905Venous Thromboembolism (VTE)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07112378Eosinophilic Esophagitis (EoE)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07142343CHAPLE Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT07154290Advanced/Metastatic Non-Small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07154745Paroxysmal Nocturnal Hemoglobinuria

clinicaltrials_gov · Retrieved 2026-04-11

NCT07175428Atrial Fibrillation (AF)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07187401Paroxysmal Nocturnal Hemoglobinuria (PNH), Persistent Anemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT07213778Symptomatic Venous Thromboembolism (VTE)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07216066Parkinsons Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT07218770Active Noninfectious Uveitis Affecting the Posterior Segment

clinicaltrials_gov · Retrieved 2026-04-11

NCT07220772Monogenic Obesity

clinicaltrials_gov · Retrieved 2026-04-11

NCT07220785Generalized Lipodystrophy

clinicaltrials_gov · Retrieved 2026-04-11

NCT07222761Relapsed and/or Refractory Multiple Myeloma (RRMM)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07230834Geographic Atrophy (GA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07235917Functional Hypothalamic Amenorrhea (FHA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07271186Diabetic Kidney Disease (DKD)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07309432Allergic Conjunctivitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT07410117Cancer-Associated Thrombosis (CAT)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07431086Overweight or Obesity

clinicaltrials_gov · Retrieved 2026-04-11

👤

Insider Activity

1

1 filing

sec_edgar · Retrieved 2026-04-11

Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.

Score Breakdown

Score Trend

2026-04-132026-06-02

Signal Summary

PDUFA Dates4

Insider Filings1

Clinical Trials5

Data Provenance

cik1 verified

clinical trial97 verified

insider buy1 verified

trial count5 verified

Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR